Free Practice Questions for the NHA Certified Phlebotomy Technician (CPT) Phlebotomy-Technician Exam (2026 Updated)

After the patient drinks the glucose solution, the phlebotomist should start timing according to the test protocol. Glucose tolerance testing depends on strict timed specimen collection after ingestion of a measured glucose load. If timing is inaccurate, the results may be invalid or misleading. The patient should not eat crackers because additional food intake can alter glucose results. Exercise should also be avoided unless specifically directed because physical activity can affect glucose metabolism. Collecting all remaining specimens immediately defeats the purpose of the timed test, which evaluates the body’s glucose response over defined intervals. The phlebotomist must verify fasting status, collect the baseline specimen if required, ensure the patient consumes the glucose solution within the allowed time, document the time finished, and collect subsequent specimens at exact ordered intervals. If the patient vomits, eats, leaves, or misses a timed draw, the phlebotomist should follow facility policy and notify appropriate personnel. Reference topics: Special Collections; glucose tolerance testing; timed specimens; patient preparation; test protocol compliance.

The appropriate dermal puncture site on an infant is the medial or lateral plantar surface of the heel. These areas reduce the risk of puncturing bone and provide suitable capillary blood flow for neonatal testing. The posterior curvature of the heel should be avoided because the bone may be close to the surface, increasing risk of osteomyelitis or injury. The arch of the foot is not an approved puncture site and may damage nerves, tendons, or deeper structures. The tip of the index finger is inappropriate for infants because there is insufficient tissue depth and greater risk of bone injury. Correct infant dermal puncture also requires using an age-appropriate lancet depth, warming the site if needed, cleaning and drying the skin, wiping away the first drop when required, avoiding excessive squeezing, and collecting specimens in the correct order. Infant blood volume is limited, so collection volume must be minimized. Reference topics: Special Collections; infant heel puncture; dermal puncture sites; neonatal safety; osteomyelitis prevention.

A prothrombin time/INR test evaluates the extrinsic and common coagulation pathways and is commonly used to monitor anticoagulant therapy, especially warfarin. Therefore, when a PT/INR point-of-care result is critically abnormal, the medication category most expected on the patient’s list is anticoagulants. Anticoagulants interfere with clot formation and can prolong PT/INR values, creating an increased bleeding risk if outside the therapeutic range. Opioids are analgesics and do not directly monitor through PT/INR. Antidiabetics are associated with glucose monitoring, not coagulation testing. Statins are lipid-lowering medications and are usually monitored through lipid panels and liver-related considerations, not PT/INR. A critical PT/INR value must be handled according to facility policy, documented accurately, and reported through the correct clinical pathway; the phlebotomist does not interpret or treat the result independently. The NHA CPT outline covers point-of-care testing, critical values for POC and CLIA-waived testing, hemostasis, coagulation, and reporting requirements. Reference topics: Special Collections; point-of-care testing; hemostasis and coagulation; critical value reporting.

==========

A small blood spill should be cleaned using an approved disinfectant according to facility policy. Blood is treated as potentially infectious, so spill response requires gloves, appropriate PPE, containment, removal of visible material, disinfection with correct contact time, and proper disposal of contaminated materials. Dry gauze alone does not disinfect the surface and can spread contamination. Air freshener has no disinfection role. Covering the spill and leaving it to dry is unsafe because dried blood may still represent a contamination hazard and creates exposure risk for staff and patients. The specific disinfectant may vary by facility, but it must be appropriate for bloodborne pathogens and used as directed. The phlebotomist must also avoid direct hand contact, dispose of materials in designated biohazard waste when required, and perform hand hygiene after glove removal. This question tests standard precautions, environmental safety, and infection-control discipline. Reference topics: Safety and Compliance; blood spill cleanup; disinfectants; standard precautions; biohazard waste.

The best site for phenylketonuria, or PKU, collection on an infant is the medial or lateral plantar surface of the heel. PKU screening is a newborn metabolic screening test commonly collected by heel stick onto filter paper. The medial and lateral heel areas are selected because they provide adequate capillary blood flow while reducing the risk of puncturing bone. The central area of the heel is unsafe because the calcaneus may be closer to the puncture site, increasing the risk of bone injury or osteomyelitis. Fingertip puncture is inappropriate for infants because the tissue is small, bone is close to the surface, and the site does not provide the recommended specimen collection area for newborn screening. Proper PKU collection also requires warming the heel when indicated, allowing blood to flow freely, filling filter-paper circles completely from one side, avoiding layering, and allowing the specimen to dry properly before transport. NHA CPT special collection content includes collecting blood for metabolic syndromes such as PKU, filter-paper collection techniques, pediatric considerations, and minimum/maximum volume requirements. Reference topics: Special Collections; PKU collection; infant heel puncture; filter-paper specimen collection.

==========

The vein is anchored by placing the thumb of the free hand below the intended puncture site and gently pulling the skin taut. This stabilizes the vein, reduces rolling, creates a firmer puncture surface, and supports accurate needle entry. Anchoring above the site is unsafe because it places the phlebotomist’s hand in the direction of needle travel and increases needlestick risk. Using two fingers instead of the thumb provides less controlled traction and may interfere with the venipuncture angle or contaminate the prepared site. The phlebotomist should avoid touching the cleansed puncture site after antisepsis unless the site is re-cleansed. Proper anchoring is especially important for superficial or mobile veins because failure to stabilize the vein can cause missed access, hematoma formation, probing, patient discomfort, or specimen collection failure. The NHA CPT outline identifies anchoring the vein below the venipuncture site and knowledge of anchoring techniques as routine venipuncture competencies. Reference topics: Routine Blood Collections; site selection; anchoring below venipuncture site; venous anatomy and safe insertion technique.

==========

Light exposure can cause a preanalytic error for serum bilirubin because bilirubin is light-sensitive. If a bilirubin specimen is exposed to light for too long, photodegradation can occur, leading to falsely decreased bilirubin results. This is why bilirubin specimens are commonly protected from light by using an amber container or wrapping the specimen in foil according to facility procedure. “Population” is not a specimen-handling variable that directly causes bilirubin degradation. “Pollutants” is too vague and does not identify the specific preanalytical issue tested here. “Location” may matter for collection site selection in some contexts, but it is not the classic handling error for bilirubin. The phlebotomist must know which specimens require special handling for light, temperature, time, transport, and processing. Failure to protect light-sensitive analytes can compromise specimen integrity before testing even begins, producing inaccurate laboratory results despite correct venipuncture technique. The NHA CPT outline directly includes maintaining specimen integrity based on handling requirements such as temperature, light, and time, as well as recognizing the impact of preanalytical errors on test results. Reference topics: Processing Specimens; bilirubin handling; light protection; preanalytical error.

==========

Newborn screening specimens are commonly collected using filter paper. These specimens are obtained by heel puncture and applied to designated circles on approved filter paper cards. The blood must soak through completely from one side, filling each circle properly without layering multiple drops. Blood cultures are collected in aerobic and anaerobic culture bottles, not filter paper. Coagulation studies require light-blue citrate tubes filled to the correct blood-to-additive ratio. Crossmatch specimens are collected in tubes specified by the transfusion service, with strict patient identification and labeling requirements. Filter-paper collection has its own technical risks: insufficient saturation, layering, contamination, touching the collection area, failure to dry completely, and improper transport can all make the specimen unsatisfactory. The phlebotomist must warm the heel if needed, use an approved puncture site, avoid excessive squeezing, and allow the card to dry horizontally away from direct heat or sunlight. Reference topics: Special Collections; newborn screening; PKU/metabolic screening; filter-paper collection; infant heel puncture.

Informed consent means the patient receives enough information to understand the nature of the procedure, including the method, purpose, risks, benefits, alternatives, and possible consequences, before agreeing. Therefore, informed consent is the correct answer. Expressed consent means the patient clearly agrees, either verbally or in writing, but the term does not by itself prove that the patient received a full explanation of risks and consequences. Implied consent occurs through the patient’s actions, such as extending an arm for venipuncture after identification and explanation. Verbal consent is simply the spoken form of agreement and may be expressed, but again it does not specifically define the full disclosure requirement. In phlebotomy, routine blood collection often proceeds with implied or expressed consent after proper identification and explanation, but higher-risk or special procedures may require more formal informed consent depending on policy. The NHA CPT outline includes receiving implied, informed, or expressed consent and understanding the components required for consent. Reference topics: Patient Preparation; patient rights; consent types; communication before collection.

==========

Recent consumption of fatty substances can elevate lipid-related analytes and can also produce lipemia, a milky or turbid appearance in serum or plasma. Therefore, the correct answer is lipid. This is why fasting status is important for certain chemistry tests, especially lipid panels or triglyceride-related testing. If the patient has not followed fasting requirements, the specimen may not reflect basal-state values and can produce misleading results. Bilirubin is primarily associated with hemoglobin breakdown and liver or biliary function; it is not directly elevated simply because the patient recently ate fatty food. Albumin is a plasma protein reflecting liver synthesis, nutrition, inflammation, or fluid status, not immediate dietary fat intake. Lipase is a pancreatic enzyme used mainly in the evaluation of pancreatic disorders and is not the same as lipids. The phlebotomist’s responsibility is to verify patient compliance with fasting, medication, timing, and basal-state requirements before collection and proceed according to facility policy. Reference topics: Patient Preparation; fasting requirements; medication and basal-state compliance; preanalytical variables.

==========

When obtaining a throat culture, the phlebotomist should swab the tonsillar area and the back of the throat because these are the clinically relevant sites for detecting organisms associated with pharyngitis, such as group A Streptococcus. The swab should avoid the tongue, cheeks, teeth, and lips because contact with those surfaces can contaminate the specimen with normal oral flora and reduce diagnostic value. Swabbing the buccal areas collects cheek-cell or oral flora material, not a proper throat specimen. Swabbing visible mucus in the oral cavity is unreliable because mucus may not represent the infected pharyngeal area. Leaving the swab in the sublingual area is inappropriate because the area under the tongue is not the target site for a throat culture. Correct technique includes explaining the procedure, positioning the patient, using a tongue depressor if needed, quickly swabbing the tonsillar pillars and posterior pharynx, placing the swab in the correct transport medium, and labeling the specimen accurately. Reference topics: Special Collections; non-blood specimen collection; throat culture technique; specimen integrity; patient instructions.

==========

If a rapidly forming hematoma develops, the phlebotomist should remove the needle and apply pressure. A hematoma occurs when blood leaks into surrounding tissue, often because the needle has gone through the vein, partially exited the vein, or the vein wall has been injured. Continuing the collection can worsen bleeding, increase pain, and compromise the specimen. Asking the patient to pump their fist increases venous pressure and can worsen leakage or alter some test results. Inserting the needle deeper is unsafe because it may worsen vessel injury or strike nearby structures. The correct response is to release the tourniquet, remove the needle, activate the safety device, apply firm pressure, and monitor the site. A bandage should be applied only after bleeding has stopped. The phlebotomist should document or report the complication according to facility policy and avoid recollecting from the affected site. Reference topics: Routine Blood Collections; hematoma; venipuncture complications; needle removal; post-procedure care.

The specimen must be redrawn in an unexpired tube. Expired additive tubes cannot be trusted because the vacuum, sterility, additive concentration, stopper integrity, and chemical performance may be compromised. Once blood has been collected into an expired additive tube, the specimen is already affected by that collection environment; transferring it into another tube does not correct the original exposure and can introduce additional hemolysis, contamination, clotting, or additive-ratio errors. Placing the specimen on ice does not reverse an expired additive problem. Submitting the specimen because the tube is “within 30 days” of expiration is unsafe; expired means expired, and laboratory acceptance criteria are based on valid collection supplies. This is a preventable preanalytical error, and the phlebotomist should also remove expired supplies from use to prevent recurrence. Tube expiration checks must occur before collection, not after the draw. Reference topics: Processing Specimens; preanalytical error; expired supplies; specimen rejection; tube quality control; recollection procedures.

==========

Ammonia is most likely to require collection in a chilled specimen tube and rapid transport, depending on facility protocol. Ammonia is unstable and can be affected by delayed processing, temperature, and cellular metabolism after collection. Chilling slows metabolic activity and helps preserve specimen integrity. Total cholesterol is generally a routine chemistry test and does not usually require immediate chilling. Hemoglobin A1c is collected to evaluate long-term glycemic control and is not typically a chilled specimen. Blood cultures require aseptic technique, correct culture bottles, adequate volume, and timely incubation or transport, not chilling. The broader lesson is that special handling requirements are analyte-specific. Some specimens must be chilled, some kept warm, some protected from light, and some delivered immediately. The phlebotomist must review the requisition, laboratory directory, or facility procedure before collection. Improper temperature handling can produce inaccurate results even if the specimen was collected in the correct tube. Reference topics: Special Collections; chilled specimens; ammonia handling; specimen stability; transport requirements.

If a patient begins convulsing during blood collection, the phlebotomist’s priority is patient safety and prevention of injury. From the choices provided, allowing the patient’s limbs to move freely is correct because the phlebotomist should not restrain the patient during a seizure. Restraining can cause musculoskeletal injury and does not stop the seizure. In actual procedure, the phlebotomist should immediately stop the draw when safe, remove the tourniquet and needle, activate the safety device, call for help, protect the patient from surrounding hazards, and follow emergency protocol. Continuing the collection is unsafe because seizure activity can cause needle movement, vein trauma, needlestick exposure, and specimen compromise. A cold compress is more relevant to swelling, bruising, or selected local complications, not active convulsions. Orange juice may be appropriate only for a conscious patient with suspected hypoglycemia who can swallow safely; it is unsafe during convulsions. The NHA CPT outline includes recognizing seizures and other complications during routine blood collection, discontinuing the draw if needed, emergency response, and first aid. Reference topics: Safety and Compliance; Routine Blood Collections; seizure response; emergency care during collection.

==========

A patient who is diaphoretic and says they feel faint requires the phlebotomist to delay collection and seek assistance. Diaphoresis, dizziness, pallor, nausea, and weakness can signal an impending syncopal episode. Continuing with venipuncture in this condition increases the risk of falls, needle injury, hematoma, and patient harm. Confirming date of birth is normal patient identification. Asking which arm will be used is a reasonable patient question and does not require delay. A visible median cubital vein is generally favorable for routine venipuncture. The phlebotomist should position the patient safely, preferably reclining or lying down if fainting risk is present, notify appropriate personnel, and proceed only when safe according to facility policy. If symptoms occur during a draw, the technician should remove the tourniquet and needle when safe, activate the safety device, call for help, and monitor the patient. Reference topics: Patient Preparation; syncope warning signs; patient assessment; collection delay; emergency response.

Allowing the antiseptic to dry before puncture helps reduce blood culture contamination. Blood cultures require strict aseptic technique because skin organisms can enter the specimen and produce false-positive results. Repalpating the site after antisepsis with an ungloved finger contaminates the prepared area and should not be done. If repalpation is absolutely necessary, facility policy may require sterile technique or repeat antisepsis. A gray-top tube is not collected before culture bottles; blood cultures are collected first in the order of draw to maintain sterility. Cleaning only the bottle cap is incomplete because both the patient’s skin and bottle access surfaces must be prepared according to procedure. Blood culture quality depends on correct skin antisepsis, adequate drying time, correct bottle order, sufficient volume, separate collection sites when ordered, and accurate documentation. Contaminated cultures can lead to unnecessary antibiotics, longer hospitalization, additional testing, and patient harm. Reference topics: Special Collections; blood cultures; contamination prevention; antiseptic drying; aseptic technique.

The phlebotomist should notify the nurse or provider according to facility policy. A competent adult patient has the right to refuse a blood draw, even when the test is ordered. Proceeding against the patient’s refusal is unethical and can constitute battery. Asking a family member to pressure the patient is inappropriate because consent must come from the patient or legally authorized representative when applicable, not from coercion. Using a smaller needle does not address refusal unless the patient specifically refused because of needle size and then gives consent after discussion. The phlebotomist should remain professional, clarify the patient’s concern within scope, avoid arguing, document or report the refusal as required, and allow authorized clinical personnel to follow up. This question tests patient rights, consent, communication, and scope of practice. Phlebotomy is invasive, so consent is not optional. The technician’s authority ends where patient refusal begins unless a specific emergency or legal policy applies through authorized medical personnel. Reference topics: Patient Preparation; patient refusal; consent; patient rights; communication; documentation.

The phlebotomist should ask, “When was the last time you had anything to eat or drink other than water?” This question directly verifies fasting status and avoids a vague yes/no answer. Patients may misunderstand fasting and think coffee, juice, gum, candy, or a small snack does not count. Asking about medication is important for some tests, but it does not verify fasting. Asking why the provider ordered the test is outside the phlebotomist’s interpretive role and may lead to unauthorized clinical discussion. Asking whether the patient has had the test before does not confirm current preparation. Accurate fasting verification is part of patient preparation and preanalytical quality control. If the patient has not fasted as required, the phlebotomist should follow facility policy, notify appropriate personnel, document noncompliance if collection proceeds, or reschedule if instructed. Poor preparation can produce misleading chemistry results and unnecessary repeat testing. Reference topics: Patient Preparation; fasting verification; patient interview; basal-state requirements; preanalytical variables.

The phlebotomist should immediately flush the eye with water at an eyewash station. Blood exposure to mucous membranes is a bloodborne pathogen exposure incident and requires immediate decontamination before administrative steps. Wiping the eye with gauze is inadequate and can irritate tissue or fail to remove infectious material. Continuing patient collections delays treatment and increases occupational risk. Applying antibiotic ointment is outside the phlebotomist’s role and does not replace proper exposure response. After flushing, the phlebotomist must report the incident according to facility policy, complete required documentation, and obtain occupational health follow-up. This may include source-patient evaluation, baseline testing, and post-exposure prophylaxis assessment when indicated. The correct professional sequence is decontaminate first, report immediately, document accurately, and follow the exposure-control plan. This question tests standard precautions, exposure control, OSHA-related safety obligations, and emergency response in the phlebotomy environment. Reference topics: Safety and Compliance; bloodborne pathogen exposure; mucous membrane exposure; eyewash use; incident reporting.

Silica promotes clot formation and is commonly used as a clot activator in serum separator tubes and other serum collection tubes. Its function is to accelerate the clotting process so serum can be separated after appropriate clotting time and centrifugation. Heparin is the opposite; it is an anticoagulant that inhibits thrombin activity and is used when plasma is required, especially for many chemistry tests. Oxalate is also an anticoagulant, commonly paired with sodium fluoride in gray-top tubes, where oxalate inhibits clotting and fluoride helps preserve glucose by inhibiting glycolysis. Citrate is another anticoagulant, usually in light-blue tubes for coagulation testing, where the blood-to-additive ratio is critical. This question tests additive function, not tube color memorization alone. A phlebotomist must know whether a tube is intended to produce serum, plasma, or whole blood because incorrect tube selection directly creates preanalytical error and possible specimen rejection. Reference topics: Routine Blood Collections; tube additives; clot activators; order of draw; specimen integrity. NHA’s CPT test plan includes equipment, collection tubes, additives, and routine blood collection procedures.

==========

Before leaving an isolation room, the phlebotomist should remove PPE according to the facility’s sequence and perform hand hygiene. PPE removal is a high-risk step because contaminated gloves, gowns, masks, or face protection can transfer organisms to the hands, clothing, supplies, or environment. Wearing the same gloves to the next room is a serious infection-control violation and can transmit pathogens between patients. Used needles must be placed immediately into an approved sharps container, not a bedside trash can. Carrying unused supplies back to a clean supply cart may contaminate the clean supply area; supplies taken into isolation rooms should be limited and handled according to facility policy. The phlebotomist should plan ahead, bring only necessary items, follow isolation signage, disinfect reusable equipment, and dispose of contaminated materials appropriately. This question tests infection-control workflow, not simply PPE recognition. Reference topics: Safety and Compliance; isolation precautions; PPE removal; hand hygiene; cross-contamination prevention.

A toxicology drug screen performed for legal, forensic, workplace, or evidentiary purposes must be accompanied by a chain-of-custody form. Chain of custody documents each person who handles the specimen, the date and time of transfer, specimen condition, identification verification, sealing, storage, and delivery. Its purpose is to prove that the specimen belongs to the correct individual and was not substituted, altered, contaminated, or mishandled. A requisition identifies the ordered test and patient/order details, but it does not provide the legal transfer record required for forensic validity. An encounter form supports visit documentation or administrative capture, not specimen evidence control. CMS 1500 is a health insurance claim form and has no role in legal specimen tracking. The phlebotomist must follow strict identification, sealing, labeling, and documentation procedures because any break in custody can invalidate the specimen for legal use. NHA CPT processing content explicitly includes chain-of-custody guidelines when required, including forensic studies and blood alcohol specimens, and special collection requirements for drug screening. Reference topics: Processing Specimens; chain of custody; drug screening; legal specimen documentation.

==========

Restating the patient’s concern for clarification demonstrates active listening. Active listening means giving attention, confirming understanding, and responding appropriately to the patient’s expressed concern. For example, if a patient says, “I always pass out,” the phlebotomist might respond, “You have fainted during blood draws before, so I’m going to position you safely and get assistance if needed.” Interrupting the patient to save time is poor communication and may cause the technician to miss safety information. Looking away while the patient speaks can appear dismissive and reduce trust. Saying all patients feel the same way minimizes the patient’s concern and is not individualized care. Active listening improves patient cooperation, consent, safety, and collection success. It also helps identify issues such as needle fear, syncope history, allergies, fasting noncompliance, language barriers, or previous complications. In phlebotomy, communication is not soft decoration; it is a safety tool. Reference topics: Patient Preparation; active listening; patient communication; anxiety reduction; patient interview.

The phlebotomist should contact a medical interpreter. A patient who speaks a different language must receive clear, accurate information about the procedure, identification process, collection requirements, and consent in a language they understand. A qualified medical interpreter is trained to communicate healthcare information accurately while preserving confidentiality and minimizing misinterpretation. A charge nurse may help coordinate care but is not automatically qualified to interpret. A unit coordinator or office manager may assist administratively, but they are not the appropriate person to explain a clinical procedure in another language unless they are formally authorized and qualified as interpreters. Family members or untrained staff should not be used for medical interpretation when a qualified interpreter is available because errors can affect consent, safety, and patient rights. The phlebotomist should pause the procedure until communication is adequate, then explain the process, verify identity, confirm understanding, and obtain appropriate consent. Reference topics: Patient Preparation; communication barriers; medical interpretation; patient rights; informed/expressed/implied consent; cultural competence.

==========

The phlebotomist should select the left antecubital area because the patient has had a right-sided mastectomy. Venipuncture should generally be avoided on the side of a mastectomy due to the risk of impaired lymphatic drainage, lymphedema, infection, and delayed healing. The right cephalic and right basilic veins are on the affected side and should not be used unless a provider specifically authorizes collection from that side. The left femoral artery is not an appropriate routine phlebotomy site and arterial collection is outside standard venipuncture practice unless performed under specialized authorization and scope. The left antecubital area is the safest option listed because it uses the unaffected arm and provides standard venipuncture access. The technician should still assess vein suitability, avoid sites with IVs, edema, scarring, hematoma, or infection, and follow facility policy if no acceptable site is available. This question tests contraindicated sites and safe site selection, not simply vein-name recall. Reference topics: Routine Blood Collections; mastectomy precautions; venipuncture site selection; contraindicated sites; patient safety.

==========

The Occupational Safety and Health Administration is responsible for workplace safety regulation, including requirements related to bloodborne pathogen exposure. In phlebotomy, bloodborne exposure incidents include needlesticks, blood splashes, mucous membrane exposure, and contact with non-intact skin. OSHA’s Bloodborne Pathogens Standard requires employers to maintain exposure control plans, provide training, use engineering controls such as safety needles and sharps containers, support appropriate PPE, and establish procedures for exposure reporting and follow-up. CMS is primarily linked to Medicare, Medicaid, and healthcare payment/quality oversight, not direct bloodborne exposure incident standards. The FDA regulates medical devices, drugs, biologics, and related safety approvals. CLIA governs laboratory testing quality standards, not occupational blood exposure response. The option wording on the screen says “Occupational Safety of Health Administration,” but the correct agency is OSHA: Occupational Safety and Health Administration. NHA CPT safety content includes OSHA, bloodborne pathogens, sharps disposal, biohazards, exposure control protocols, needlestick reporting, and workplace safety regulations. Reference topics: Safety and Compliance; OSHA; Bloodborne Pathogens Standard; exposure control protocols.

==========

The best initial introduction is to knock on the door, greet the patient, and introduce themselves. This sequence respects privacy, establishes professional presence, and begins communication before any technical identification or collection step. Entering quietly without first knocking may be inappropriate in a patient-care environment because the patient has a right to privacy and dignity. Turning on lights immediately can be abrupt, especially for hospitalized patients who may be resting, anxious, or ill. Checking the ID band is essential, but it follows professional entry and introduction. Checking the provider’s prescription or order is important before collection, but it is not the interpersonal “initial introduction” step at bedside. The correct approach supports patient cooperation, consent, and safety. After introduction, the phlebotomist should verify the order, use two identifiers, explain the procedure, assess patient readiness, and obtain consent according to facility policy. Reference topics: Patient Preparation; therapeutic communication; patient rights; bedside approach; patient identification; consent. NHA’s CPT test plan includes patient communication and preparation as a major domain.

==========

The best response is, “Your provider can explain what the result means.” Phlebotomists may explain collection procedures, specimen requirements, and general process steps, but they should not interpret laboratory results, diagnose conditions, or speculate about disease severity. Telling the patient the condition is serious is outside scope and may be inaccurate. Advising the patient to search online is unprofessional and can increase confusion or anxiety. Suggesting the laboratory made an error is also inappropriate unless an authorized investigation has identified an error. The correct response protects patient safety, scope of practice, and communication integrity. Laboratory results must be interpreted in clinical context, including history, medications, symptoms, other test results, and provider assessment. The phlebotomist should route result questions to the ordering provider or authorized clinical staff according to facility policy. This question tests professionalism and communication boundaries. Reference topics: Patient Preparation; scope of practice; patient communication; result interpretation; professional conduct.

For a forensic blood alcohol level, the phlebotomist should document use of a non-alcohol-based preparation, represented here by chlorhexidine preparation rather than ethanol or isopropyl alcohol. The critical issue is legal defensibility: using an alcohol-containing skin antiseptic can create a challenge that the collection process contaminated or affected the blood alcohol evidence. Ethanol and isopropyl alcohol are both inappropriate choices for this context because they are alcohols. The direction of rubbing ethanol—up and down or circular—is irrelevant; the problem is the substance itself. Chlorhexidine is the only non-ethanol/non-isopropyl option listed and is therefore the correct answer, assuming the facility’s forensic kit or protocol specifies an acceptable non-alcohol preparation. The phlebotomist must also maintain chain of custody, identify the patient/donor correctly, use the proper tube, seal the specimen, document collection time, and transfer the specimen according to legal procedure. Reference topics: Special Collections; blood alcohol collection; forensic specimens; chain of custody; documentation. NHA’s CPT outline includes forensic studies and chain-of-custody collection requirements.

==========

The phlebotomist should put on gloves before palpating a vein. Gloves are required because the phlebotomist is preparing for an invasive procedure with potential blood exposure. Palpation helps assess vein size, depth, direction, resilience, and suitability, but it must occur after hand hygiene and glove application. Removing the needle cap before site selection is unsafe because it exposes the needle unnecessarily and increases needlestick risk. Labeling collection tubes before collection is improper because tubes must be labeled after collection in the presence of the patient to prevent misidentification. Asking the patient to bend the arm is not appropriate for vein palpation and is especially unsafe after needle removal because bending the arm can cause hematoma formation. The correct sequence is patient identification, hand hygiene, gloves, position patient, apply tourniquet, select/palpate vein, release/reapply tourniquet as needed, clean site, allow antiseptic to dry, anchor, and perform venipuncture. Reference topics: Routine Blood Collections; glove use; vein palpation; venipuncture sequence; patient safety.

Quality control testing should be performed before using a new lot number of point-of-care testing strips. Lot-to-lot variation can affect test performance, and QC confirms that the strips, controls, meter, and operator process are producing acceptable results before patient testing begins. Freezing strips is incorrect unless a manufacturer specifically requires a storage condition, and most reagent strips have controlled storage requirements that must not be improvised. Mixing old and new lots is unsafe because it creates traceability problems and can invalidate quality control. Using strips only for “control patients” is meaningless; patient specimens should not be used to validate unverified supplies. For waived testing and point-of-care testing, the phlebotomist must follow manufacturer instructions, document QC results, check expiration dates, store materials properly, and stop patient testing when controls fail. If QC is outside range, patient results should not be reported until corrective action is completed. Reference topics: Safety and Compliance; Special Collections; point-of-care testing; quality control; reagent lot verification.